Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
Jason V. Gregory, Padma Kadiyala, Robert Doherty, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

The blood–brain barrier: Structure, regulation and drug delivery
Di Wu, Qi Chen, Xiaojie Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 629
Absorption, distribution, metabolism, excretion and toxicity of microplastics in the human body and health implications
Pengfei Wu, Siyi Lin, Guodong Cao, et al.
Journal of Hazardous Materials (2022) Vol. 437, pp. 129361-129361
Closed Access | Times Cited: 232
Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology
Andrew M. Hersh, Safwan Alomari, Betty Tyler
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4153-4153
Open Access | Times Cited: 219
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
Kirk Brown, Jayaprakash K. Nair, Maja M. Janas, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 10, pp. 1500-1508
Open Access | Times Cited: 163
Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood–Brain Barrier for Chemo-immunotherapy against Glioblastoma
Jiwei Cui, Xue Wang, Jinge Li, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 1464-1484
Closed Access | Times Cited: 133
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Ksenia A. Mitusova, Oleksii O. Peltek, Timofey E. Karpov, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 113
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 103
Systemic Delivery of an Adjuvant CXCR4–CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy
Mahmoud S. Alghamri, Kaushik Banerjee, Anzar Mujeeb, et al.
ACS Nano (2022) Vol. 16, Iss. 6, pp. 8729-8750
Open Access | Times Cited: 89
Tumor–Antigen Activated Dendritic Cell Membrane-Coated Biomimetic Nanoparticles with Orchestrating Immune Responses Promote Therapeutic Efficacy against Glioma
Xiaoyue Ma, Lei Kuang, Ying Yin, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2341-2355
Closed Access | Times Cited: 89
Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
Congcong Wang, Ning Li, Yutian Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches
Nahal Habibi, Ava Mauser, Yeongun Ko, et al.
Advanced Science (2022) Vol. 9, Iss. 8
Open Access | Times Cited: 75
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 31
Receptor Ligand-Free Mesoporous Silica Nanoparticles: A Streamlined Strategy for Targeted Drug Delivery across the Blood–Brain Barrier
Zih-An Chen, C.‐H. Wu, Si‐Han Wu, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12716-12736
Open Access | Times Cited: 25
Efficient Delivery of Lomitapide using Hybrid Membrane‐Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy
Mingming Song, Jiameng Tian, Wang Li, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 18
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Jun Liao, Wenxiu He, Lisha Li, et al.
(2025), pp. 100016-100016
Open Access | Times Cited: 3
Nanostructured lipid carriers for enhanced batimastat delivery across the blood–brain barrier: an in vitro study for glioblastoma treatment
Miguel Horta, Paula Soares, Bruno Sarmento, et al.
Drug Delivery and Translational Research (2025)
Closed Access | Times Cited: 2
Cation‐Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy
Tong Jiang, Yonghan Qiao, Weimin Ruan, et al.
Advanced Materials (2021) Vol. 33, Iss. 45
Closed Access | Times Cited: 100
Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation
Jacob W. Myerson, Priyal Patel, Kathryn M. Rubey, et al.
Nature Nanotechnology (2021) Vol. 17, Iss. 1, pp. 86-97
Open Access | Times Cited: 91
Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis
Hao Li, Meng Wang, Biao Huang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 84
Current Approaches for Glioma Gene Therapy and Virotherapy
Kaushik Banerjee, Felipe J. Núñez, Santiago Haase, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 77
RNA-based therapeutics for neurological diseases
Karen Anthony
RNA Biology (2022) Vol. 19, Iss. 1, pp. 176-190
Open Access | Times Cited: 59
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Priya Yadav, Suresh V. Ambudkar, N. Rajendra Prasad
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 57
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
João Victor Roza Cruz, Carolina Batista, Bernardo de Holanda Afonso, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3203-3203
Open Access | Times Cited: 55
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
Daniel Kreatsoulas, Chelsea Bolyard, Bill X. Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top